Fabric Genomics & Kahn Swick & Foti

Fabric Genomics: Fabric Genomics was acquired by GeneDx Holdings Corporation, and its viability and importance were allegedly misrepresented, leading to a significant impairment loss for GeneDx Holdings Corporation and contributing to the securities fraud allegations.

Kahn Swick & Foti: Kahn Swick & Foti is a law firm that has reminded investors of the deadline to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corporation.

Fabric Genomics: Fabric Genomics is the acquired company at the center of the alleged misrepresentations. GeneDx Holdings Corporation recorded a $31.2 million impairment loss, wiping out about 94% of the cash paid for it. The acquisition's failure is the core issue in the lawsuit.

Kahn Swick & Foti: Kahn Swick & Foti is one of the law firms representing investors in the class action. The firm is actively reminding investors of the August 3, 2026 lead plaintiff deadline and is seeking to recover losses for shareholders.